Glycerol monolaurate (GML) is a monoglyceride with potent antimicrobial properties that suppresses T cell receptor (TCR)-induced signaling and T cell effector function. Actin rearrangement is needed for the interaction of T cells with antigen-presenting cells and for migration to sites of infection. Because of the critical role actin rearrangement plays in T cell effector function, we analyzed the effect of GML on the rearrangement of the actin cytoskeleton after TCR activation. We found that GML-treated human T cells were less adherent than untreated T cells and did not form actin ring structures but instead developed numerous inappropriate actin-mediated filopodia. The formation of these filopodia was not due to disruption of TCR-proximal regulators of actin or microtubule polymerization. Instead, total internal reflection fluorescence microscopy demonstrated mislocalization of actin nucleation protein Arp2 microclusters, but not those containing the adaptor proteins SLP-76 and WASp, or the actin nucleation protein ARPC3, which are necessary for TCR-induced actin rearrangement. Additionally, SLP-76 microclusters colocalized with WASp and WAVE microclusters but not with LAT. Together, our data suggest that GML alters actin cytoskeletal rearrangements and identify diverse functions for GML as a T cell-suppressive agent.
INTRODUCTION
T cells encounter and respond to various stimuli by sensing specific peptide-MHC (major histocompatibility complex) complexes on antigenpresenting cells (APCs) through the T cell receptor (TCR) (1) . TCR signaling cascades connect extrinsic activation signals with actin polymerization pathways that regulate intracellular signaling, adhesion, and migration of T cells (2, 3) . TCR activation at the original point of contact between the T cell and the APC results in an expanding wave of lamellar actin that maximizes surface contact between these cells. This stimulates T cells to form a dense actin network at the periphery of the cell that is rich in adhesive structures, termed the distal supermolecular activation cluster (dSMAC) (3) . The dSMAC surrounds a region rich in actomyosin structures called the peripheral supermolecular activation cluster (pSMAC), which contains large multiprotein signaling clusters (3) . Retrograde movement of actin from the dSMAC and actomyosin "arcs" from the pSMAC are critical to accumulate signaling complexes in the center of the cell and drive the formation of an actin-depleted central supermolecular activation cluster (cSMAC) (2) (3) (4) . Together, the dSMAC, pSMAC, and cSMAC form the immunological synapse, which is necessary for TCR signal transduction and T cell function.
The formation of the actin structures at the dSMAC and pSMAC is regulated by two classes of actin nucleation factors, the formin family and the actin related protein 2/actin related protein 3 (Arp2/3) complex. These proteins compete for actin monomers and negatively regulate each other's function (5, 6) . Formins bind to the barbed edge of actin filaments and prevent the association of actin with actin-capping proteins (7) . Formins regulate the assembly of structures in the pSMAC and are critical for the retrograde flow of signaling clusters into the cSMAC (8, 9) . In contrast, the activated Arp2/3 complex mediates the branching of actin filaments that ultimately drives the formation of the dense lamellipodia structures in the dSMAC (8, 10) . The Arp2/3 complex is activated by actin nucleationpromoting factors, such as the Wiskott-Aldrich Syndrome protein (WASp) and WASp family verprolin-homologous protein-2 (WAVE2) (11) (12) (13) (14) , which have distinct functions in actin rearrangement in T cells. WAVE2 promotes the formation of lamellar actin structures found in the dSMAC (13) (14) (15) , whereas WASp regulates actin structures associated with signaling complexes in the pSMAC (3, 15, 16) . The activation of both WASp and WAVE2 requires the adaptor protein linker for activation of T cells (LAT) (15) . LAT phosphorylation promotes recruitment of the adaptor protein SLP-76 (or SH2 domain-containing leukocyte protein of 76 kDa) and its binding partners. This leads to the activation of the small guanosine triphosphatases (GTPases) CDC42 (or cell division control protein 42 homolog) and Rac1 (Rac family small GTPase 1), which are critical for the activation of WASp and WAVE2 (17, 18) . Both WASp and WAVE2 colocalize with LAT-and SLP-76-containing clusters at early time points after T cell activation but then migrate to different cellular structures at later times (14) . Thus, TCR activation stimulates dynamic actin polymerization that is tightly controlled by the formation of LAT-dependent signaling complexes.
Triglycerides containing the 12-carbon fatty acid lauric acid exist naturally in mammalian breast milk and coconut oil. Lauric acid triglyceride is metabolized to the monoglyceride glycerol monolaurate (GML), where it is absorbed in the intestine (19) . GML is on the U.S. Food and Drug Administration's Generally Recognized as Safe list and incorporated in numerous commercial products, such as deodorants, lotions, cosmetics, food preservatives, and homeopathic supplements (20) (21) (22) . GML has potent antimicrobial properties and suppresses the growth and virulence of a broad spectrum of pathogens, including Gram-positive and Gram-negative bacteria, select fungi species, and enveloped viruses (23) (24) (25) (26) (27) . Because of this, topical GML is currently being tested as a therapeutic for toxic shock syndrome, HIV transmission, and surgical site infections (28) (29) (30) . However, GML also suppresses T cell activation by disturbing ordered lipid domains in the plasma membrane, which leads to reduced formation of punctate signaling clusters of LAT and phospholipase C-1 (PLC-1) (31) (32) (33) . This in turn leads to defective PLC-1-mediated cytosolic calcium influx, PI3K (PI 3-kinase) and AKT activation, and, ultimately, reduced cellular proliferation and cytokine production.
Because of the intimate link between T cell activation and cytoskeletal rearrangement, we hypothesized that GML affected the function of the T cell cytoskeleton. To test this, we characterized how GML affected actin polymerization in human T cells. We observed that GML reduced TCR-mediated cellular adhesion and disrupted actin ring formation. The actin molecules instead formed aberrant filopodia structures at the plasma membrane due to the increased activation of the Arp2/3 complex. Mislocalization of SLP-76, WASp, WAVE2, and the actin related protein 2/3 complex subunit 3 (ARPC3) protein subunit of the Arp2/3 complex away from clusters of Arp2 resulted from the impaired association between LAT and SLP-76 microcluster units at the plasma membrane. Together, these findings suggest that GML disrupted the formation of microclusters of signaling protein that are necessary for appropriate actin cytoskeletal rearrangements in T cells.
RESULTS
GML disrupts actin ring formation and stimulates development of filopodia structures GML inhibits T cell effector functions by disrupting the ordered lipid domains and LAT microclusters at the plasma membrane that are necessary for efficient TCR signaling (33) . Because formation of the LAT signaling complexes directly affects actin polymerization (11, 14, 34) and filamentous actin is enriched in ordered lipid domains after TCR activation (35, 36) , we investigated whether GML also affected the cellular adhesion and actin dynamics required for TCR signaling. Using a fluorescence-based plate adherence assay (37), we found that GMLtreated human T cells were less adherent than vehicle-treated T cells (Fig. 1A) . This defect was dose-dependent and statistically significant at higher concentrations of GML. Assessing actin ring formation, we found that, consistent with previous reports (34, 37, 38) , T cells activated with anti-CD3 coated on planar surfaces spread and formed a ring of polymerized actin molecules along the periphery of the cell contact (Fig. 1B) . Furthermore, when quantifying the intensity of actin polymerization along the central axis of the cell, two peaks with high pixel intensity values that correlated with actin-rich regions at the cell edges were observed. In contrast, GML-treated T cells did not form an intact actin ring (Fig. 1B) . These results suggest that GML reduces cellular adhesion due to improper formation of actin ring structures at the cell periphery.
We observed that the GML-treated cells developed protrusive structures that were positive for phalloidin staining under epifluorescence. To further characterize these actin structures at the plasma membrane, we used total internal reflection fluorescence (TIRF) microscopy, which enabled us to isolate the imaging plane within 150 nm of the T cell membrane contact site. In contrast to control T cells, which had cortical actin staining at the membrane without protrusions, GMLtreated T cells developed numerous long, thin filopodia (Fig. 1C) . Quantification showed that GML-treated T cells had, on average, ~20 filopodia that were greater than 2 m in length as compared to ~2 filopodia in control T cells. In addition, the mean length of the longest filopodium in GML-treated T cells was ~12 m, but was less than 2 m in control T cells (Fig. 1D) . The effects of GML were quite rapid. After only 5 min of exposure, GML-treated T cells developed significantly more filopodial structures of >1 m than did the control T cells ( fig. S1 ). These results show that GML induces aberrant actin-mediated filopodia structures after TCR stimulation.
GML does not affect proximal TCR signaling or regulators of actin polymerization
Because GML disrupts the formation of LAT-PLC-1-AKT microclusters at the cell membrane (33), we tested the effect of GML on the activation of other TCR signaling proteins that regulate actin polym erization, such as the Src family kinases lymphocyte cell-specific protein-tyrosine kinase (Lck) and Fyn, focal adhesion kinase (FAK), protein tyrosine kinase 2  (PTK2 or Pyk2), and paxillin (37, (39) (40) (41) . We found that GML-treated T cells had no defect in the phosphorylation of Lck and Fyn (Y416), FAK (Y397), Pyk2 (Y402), or paxillin (Y31) after TCR stimulation (Fig. 2) . These data indicate that GML does not affect the activation of key signaling regulators upstream of actin polymerization.
Formin function is critical for GML-mediated filopodia formation
Filopodia formation depends on formin-dependent polymerization of parallel actin fibers and microtubule bundling (42) (43) (44) . To determine which activity was affected by GML, we used small-molecule inhibitors to block GML-dependent filopodia formation. Activated T cells treated with colchicine, an inhibitor of microtubule polymerization, did not resemble GML-treated T cells by gross appearance (45) and formed fewer, shorter filopodia than did GML-treated T cells (Fig. 3A) . Activated T cells treated with GML alone or concurrently with GML and colchicine had similar numbers of filopodia structures. However, the filopodia in the cells treated with both GML and colchicine were significantly longer in length, averaging ~20 m compared to ~10 m for the T cells treated with GML alone. These data suggest that GML regulates filopodia formation independently of microtubule polymerization. To disrupt formin-actin filament interactions, we used SMIFH2 (small-molecule inhibitor of formin homology 2 domains), which does not affect Arp2/3 complex-dependent cytoskeletal structures (46) . Similar to colchicine-treated cells, activated T cells treated with SMIFH2 did not resemble GML-treated cells but developed fewer, shorter filopodia compared to those of T cells treated with GML alone (Fig. 3B ). Furthermore, activated T cells treated with both SMIFH2 and GML displayed fewer filopodia than did T cells treated with GML alone. Additionally, the filopodia induced after GML treatment were shorter in the presence of SMIFH2 than in its absence. These data suggest that the filopodia formed after GML treatment are driven by the function of formins.
GML stimulates formation of filopodia structures through Arp2/3 complex dysfunction
The polarized filopodia structures formed after GML treatment are phenotypically similar to structures found in Arp2-and Arp3-deficient T cells or T cells treated with Arp2/3 inhibitors (8, 9) . To determine whether GML induced filopodia formation by inhibiting Arp2/3 complex activity, we used the small-molecule inhibitor CK-666, which stabilizes the inactive state of the Arp2/3 complex by preventing the Arp2 and Arp3 subunits from moving into the activated filament-like conformation (47) . In contrast to inhibitors of microtubules and formins, CK-666 stimulated formation of filopodia that were similar in appearance, number, and length to those observed in GML-treated T cells (Fig. 3C ). Furthermore, activated T cells treated with both CK-666 and GML developed filopodia structures that were unchanged as compared to those in T cells treated with CK-666 or GML alone. These data suggest that GML caused Arp2/3 complex dysfunction, which induced the formation of abnormal filopodial structures in activated T cells.
GML does not alter the activation or membrane clustering of the Arp2/3 complex
Because GML appeared to dysregulate Arp2/3 complex function, we examined whether GML affected the activation of Rac1, CDC42, and WASp, key regulatory molecules of Arp2/3 activation. To measure the activation of Rac1 and CDC42, we used agarose beads bound to the activated Rac1-and CDC42-binding domain of human p21-activated kinase 1 protein (48). We found that treatment of T cells with GML did not alter Rac1 or CDC42 activation compared to that in control cells for all times tested (Fig. 4A) . Furthermore, we examined whether GML affected the total protein amounts of WASp, Arp2, and ARPC3, as well as the TCR-stimulated phosphorylation of WASp by Western blotting. We found that GML did not alter the total amounts of these proteins, nor did it affect the phosphorylation of WASp at Tyr 290 ( Fig. 4 , B and C). These data suggest that GML does not substantially alter the amounts or the activation of Arp2/3 complex regulatory molecules.
TCR activation results in the formation of membrane-localized microclusters that are highly enriched in the signaling adaptor LAT, which associates with the actin nucleation factor WASp (34, (49) (50) (51) . Because GML reduces the extent of LAT microcluster formation at the membrane (33), we used TIRF microscopy to test whether GML altered the recruitment of WASp and components of the Arp2/3 complex to LAT microclusters. We found that GML did not alter the formation of microclusters of Arp2, phosphorylated WASp, ARPC3, and phosphorylated SLP-76 as compared to that in control cells (Fig. 5 ). In addition, no differences in WASp-ARPC3 association were detected by co-immunoprecipitation studies (Fig. 6A) .
GML causes defective localization of WASp, ARPC3, and SLP-76 by preventing the colocalization of LAT and SLP-76 microclusters Although our earlier results showed that all components of the Arp2/3 complex clustered at the plasma membrane after T cell activation regardless of treatment, we noted that the membrane and filopodia microclustering patterns of WASp, ARPC3, and SLP-76 were different from that of Arp2 (Fig. 5) . To further investigate these differences, we analyzed the localization of Arp2, WASp, ARPC3, and SLP-76 in greater detail in GML-treated T cells using TIRF microscopy. We found that, whereas Arp2 was only present within the contours of the cell border, phosphorylated WASP, ARPC3, and phosphorylated SLP-76 were positively stained in the filopodial structures induced by GML (Fig. 6B,  top) . We quantified this phenomenon by counting the number of fluorescently positive filopodial structures per T cell in control and GML-treated cells. Quantitation of Arp2-stained cells confirmed the minimal localization of this protein within filopodia regardless of treatment. However, WASp, ARPC3, and SLP-76 exhibited significantly increased localization to filopodia only after GML treatment (Fig. 6B , bottom). These data suggest that GML alters the localization of WASp, ARPC3, and SLP-76, but not Arp2, in activated T cells. WASp and ARPC3 are downstream of SLP-76-mediated signaling (34, 52) . To determine whether GML altered the localization of WASp and ARPC3 in activated T cells by abrogating the association of upstream signaling microclusters, we analyzed the localization of phosphorylated SLP-76 and phosphorylated LAT by TIRF microscopy. Consistent with our previous study (33), we observed that the treatment of T cells with GML suppressed the formation of phosphorylated LAT microclusters but not phosphorylated SLP-76 microclusters (Fig. 6C) , which also exhibited reduced colocalization with phosphorylated SLP-76 microclusters. Therefore, GML may also disturb the interaction between LAT microclusters and SLP-76 microclusters.
GML does not prevent the association of WASp and WAVE2
with LAT-independent SLP-76 microclusters SLP-76 microclusters can form independently of LAT microclusters (53 microscopy, we found that GML did not affect the association between phosphorylated SLP-76 microclusters and phosphorylated WASp microclusters in activated T cells (Fig. 7A) or between phosphorylated SLP-76 microclusters and phosphorylated WAVE2 microclusters (Fig. 7B ). We also found that similar to phosphorylated WASp microclusters, phosphorylated WAVE2 microclusters were localized within filopodia in GML-treated T cells (Fig. 7C ). These data suggest that GML may decrease the association between SLP-76 microclusters and LAT microclusters, but spare their association with WASp and WAVE2.
DISCUSSION
Our data suggest that aberrant filopodia formation after treatment of activated T cells with GML may result from dysregulation of LAT and SLP-76 microclusters. In unstimulated cells, LAT is organized in nanocluster-scale units that are composed of five molecules or less. After TCR activation, these proteins oligomerize into microcluster-scale units that are composed of >25 molecules (49) (50) (51) (53) (54) (55) . However, there is a disconnect between SLP-76-and LAT-mediated signaling. Inhibition of actin polymerization by latrunculin A substantially inhibits LAT clustering, but not SLP-76 clustering (53) . In addition, T cells deficient in Gads, an adaptor protein that canonically links SLP-76 to LAT, exhibit suppressed PLC-1-mediated responses because of the recruitment of PLC-1 to LAT microclusters (56), but no defect in SLP-76 phosphorylation or downstream actin polymerization (56) . Finally, whereas both TCR stimulation and integrin activation lead to the formation of SLP-76 microclusters, only TCR stimulation results in the formation of LAT microclusters (57) . Thus, SLP-76 clusters exist in two populations, those that are recruited to LAT microclusters and those that are not. The LAT-dependent and LAT-independent SLP-76 clusters have distinct functions. LAT-independent SLP-76 clusters can activate WASp through the canonical signaling pathway involving Nck, Vav, Rac1, and CDC42 (52) . In support of this, we found that GML-treated T cells did not have altered Rac1 or CDC42 activation (Fig. 4A) ; Arp2, WASp, WAVE2, ARPC3, or SLP-76 microcluster formation (Figs. 5 and 7) (33); or ARPC3-WASp association (Fig. 6A) . In contrast, LAT-dependent SLP-76 clusters have a direct role in activating the Arp2/3 complex and actin polymerization. After TCR engagement, WASp and WAVE2 are rapidly recruited to the LAT signaling complex (14, 58) , although they disassociate to form separate structures after longer stimulation times (14) . The association of WASp, WAVE2, and SLP-76 with LAT may be important for coordinating the correct spatial context to initiate the actin polymerization necessary for dSMAC and pSMAC formation. Under normal conditions, LAT microclusters are associated with SLP-76 microclusters after TCR activation. This leads to the canonical activation of WASp, WAVE2, and the Arp2/3 complex; actin polymerization; lamellipodia formation; and cellular adhesion ( fig. S2A ). We found that GML disrupted the formation of LAT microclusters, which suggests that LAT-independent SLP-76 microclusters are the predominant type of SLP-76 microcluster. Our data imply that LAT-independent SLP-76 microclusters may drive the altered localization of WASp, WAVE2, and the ARPC3 subunit of the Arp2/3 complex. In addition, the reduced association of the ARPC3 and Arp2 subunits likely contributed to Arp2/3 complex dysfunction and stimulated filopodia formation ( fig. S2B ). The Arp2/3 complex is composed of the actin-like subunits Arp2 and Arp3 with five additional subunits, ARPC1 to ARPC5, which mediate actin branching by nucleating new actin filaments (59) . Arp2 and Arp3 associate with the pointed end of the newly polymerizing actin filament, whereas ARPC2 and ARPC4 are important subunits that interact with the parental filament; the other subunits, ARPC1, ARPC3, and ARPC5, have regulatory roles (60, 61) . In particular, the ARPC3 subunit regulates the actin nucleation activity of the complex. ARPC3 is implicated in cross-talk between the Arp2/3 complex and nucleation-promoting factors, such as WASp and WAVE2 (62) (63) (64) . Furthermore, a purified recombinant Arp2/3 complex that lacks ARPC3 nucleates actin filaments at a considerably slower rate than does the full Arp2/3 complex (65). We observed that, although GML-treated T cells had intact Rac1, CDC42, and WASp activation, they exhibited the mislocalization of ARPC3 from Arp2. These data support the model that ARPC3 is critical for Arp2/3 complex activity. Furthermore, our data imply that ARPC3 may be an important signaling intermediate between WASp and the Arp2/3 complex, and that lack of proper ARPC3 localization could result in defective Arp2/3 complex function. In addition, decreased Arp2/3 complex formation may increase the activation of the formins that are necessary for the formation of the actin cytoskeleton (9) . In support of this, we found that formin inhibition decreased the GMLinduced formation of filopodial structures in T cells (Fig. 3B) .
Overall, our observations shed light on how GML suppresses T cells and provide insight into the therapeutic applications of GML. Whereas GML reduces T cell function by disturbing ordered lipid microdomains in the plasma membrane (33) and altering actin polymerization, these pathways likely synergize to inhibit cytokine production. Impairment of T cell activation by GML warrants the further investigation of GML as an immunosuppressant. However, the T cell-suppressive property of GML is likely limited to topical applications because of the strong binding affinity of albumin that renders GML biologically inactive in the circulation (66) . Topical GML formulations could suppress T cell responses and ameliorate skin diseases, such as eczema and psoriasis, whereas oral ingestion of GML may reduce gut inflammation in Crohn's disease and ulcerative colitis. In addition, GML incorporated into tampons or prophylactics could inhibit pathological T cell activation at the vaginal mucosal site and suppress chemokine receptor proteins that are important for HIV viral entry. In these mucosal sites, only doses greater than 20 g/ml retain biological activity and are able to suppress T cell function (66) . Because we did not use media containing albumin in our experiments, we found that GML exerted its effects at doses less than 20 g/ml, which is consistent with other published work describing its effects (24, 33) . These concentrations are achievable in a clinical setting.
Vaginal treatment with GML (5 mg/ml) in an ethanol gel resulted in a two-log decrease in the counts of Candida species (25), equivalent to the growth reduction achieved in vitro with GML at a concentration of 100 g/ml (25) . Finally, the antibiotic properties of GML synergize with its T cell-suppressive properties to treat both the pathogen and host aspects of infectious disease pathology. For example, GML inhibits both staphylococcal virulence and the T cell-mediated cytokine storm in menstruation-associated toxic shock syndrome. Together, our data suggest that GML could be used as an immunosuppressive agent for T cell functions, which disturbs both actin cytoskeletal rearrangement and plasma membrane lipid-mediated signaling after TCR activation.
MATERIALS AND METHODS

Primary human T cell isolation and GML preparation
Whole blood was obtained from de-identified healthy donors at the DeGowin Blood Center at the University of Iowa Hospitals and Clinics. The recruitment protocol and written informed consent document were approved by the Institutional Review Board for the University of Iowa. Peripheral blood mononuclear cells were isolated from leukocyte reduction system cones using Hypaque-Ficoll density-gradient separation as previously described (33) . T cells were then expanded and activated with anti-CD3-and anti-CD28-coated beads (Invitrogen) and human interleukin-2 (IL-2) for 5 days. Cells were then resuspended in fresh medium without stimulatory beads or IL-2 for 24 hours. Activated T cells were resuspended in serum-free RPMI 1640 before GML treatment. GML was solubilized at room temperature in 95% ethanol and diluted into the appropriate working concentration. We added 95% ethanol as a comparative vehicle control at final concentrations that did not exceed 0.5%. Activated T cells were treated with ethanol or various doses of GML in serum-free medium for various assays.
Plate-bound adhesion assay
The plate-bound adhesion assay was performed as previously described (37) . Briefly, RIA/EIA (radioimmunoassay/enzyme immunoassay) plates were coated overnight at 4°C with anti-CD3 antibodies diluted in phosphate-buffered saline (PBS). The plates were washed three times with PBS and blocked with 1% bovine serum albumin in PBS for 2 hours at 37°C. Activated T cells were stained with the LI-COR CellVue Burgundy kit (LI-COR), treated with GML or ethanol, and added to the wells of the blocked anti-CD3-coated plates for 15 min. Nonadherent cells were washed off, and adherent cells were imaged using the LI-COR Odyssey Infrared Imager.
Western blotting
Activated T cells were treated with GML (10 g/ml) or ethanol (0.1%) control and then incubated on ice with anti-CD3 and anti-CD4 antibodies for 20 min. Cells were then incubated at 37°C for 10 min and stimulated with immunoglobulin G (IgG) cross-linking antibody for various times. Both anti-CD3 and anti-CD4 antibodies were used because detectable TCR-mediated signaling is optimally detectable using both anti-CD3 and anti-CD4 antibodies and not anti-CD3 antibody alone (67 . In Rac1/CDC42 activation experiments, lysates were incubated with the human p21 activated kinase 1 Rac/Cdc42 (p21) binding domain (PAK-PBD) glutathione-conjugated agarose beads (Cytoskeleton) overnight at 4°C. The samples were washed and eluted, and the bound proteins were detected by Western blotting. Band intensity was quantified using Odyssey's v3.0 software. To minimize variability between human donors, band intensities were further normalized to the band intensity of the 2-minute time point for the ethanol treatment.
TIRF and epifluorescence microscopy Activated T cells were stimulated in the presence of ethanol or GML with plate-bound anti-CD3 on glass coverslips for 15 min. In experiments with inhibitors of cytoskeletal processes, 100 M colchicine (Cayman Chemical), 10 M SMIFH2 (Calbiochem), or 10 M CK-666 (Calbiochem) solubilized in dimethyl sulfoxide was added to the activated T cells at the same time as the GML or solvent. Cells were fixed with 4% paraformaldehyde for 30 min, permeabilized with 0.25% Triton X-100 for 5 min, and then stained with the appropriate reagents. To detect actin, tetramethylrhodamine (TMR)-phalloidin (Sigma-Aldrich) was incubated with the fixed and permeabilized cells for 2 hours at 37°C. To detect microcluster formation of signaling proteins, cells were stained with antibodies specific for Arp2 (Cell Signaling), WAVE2 (Cell Signaling), phosphorylated WASp Y290 (Invitrogen), ARPC3 (Millipore), phosphorylated SLP-76 Y128 (BD Pharmingen), and phosphorylated LAT Y191 (Millipore). Staining was detected with the conjugated secondary antibodies DyLight 488 goat anti-rabbit IgG or Alexa Fluor 568 goat anti-mouse IgG1 (Thermo Fisher Scientific). TIRF images were captured by the Leica AM TIRF MC system using a 100× magnification oil immersion objective lens at the University of Iowa Central Microscopy Research Facility. Actin ring structures were imaged using the same microscope using the epifluorescence channels.
Image quantification
Microscopy images were processed and analyzed with ImageJ software. Quantification of membrane clustering was performed by measuring the mean pixel intensity in the longest axis of cells. Quantification of filopodial structures was performed by measuring the length of the longest protruding filopodium per cell and counting the number of filopodial structures that were longer than 2 m per cell. Quantification of actin ring structures was performed with the Plot Profile tool in ImageJ to obtain pixel intensity values along the long cell axis. Quantification of WASp-, Arp2-, or ARPC3-positive filopodial structures was performed by counting the number of filopodial structures that were longer than 2 m per cell. Pixel colocalization analysis was performed with the Coloc 2 plugin in ImageJ. The Manders correlation coefficient was determined using this method and plotted.
Statistical analysis
Statistical analysis was performed with GraphPad Prism using statistical tests appropriate for the experimental data. The individual tests used for each analysis are described in the figure legends. All statistical analysis of Western blotting data was performed with paired analysis. All statistical analysis was performed in consultation with the Biostatistics Core Facility in the Holden Comprehensive Cancer Center at the University of Iowa.
SUPPLEMENTARY MATERIALS
www.sciencesignaling.org/cgi/content/full/11/528/eaam9095/DC1 Fig. S1 . Time course of GML-induced filopodia formation. Fig. S2 . Model depicting the effects of GML on T cell adhesion.
